Status: Active
-
Using T-Cell signals to detect and track gliomas
-
Identifying unique protein markers in brain tumours to develop new immune-based treatments
-
Understanding the origin of meningiomas to develop targeted treatments
-
Using the immune response to target glioblastoma
-
Exploring the use of “smart viruses” to treat glioblastoma
-
Targeting protein kinases to develop effective drugs for glioblastoma
-
Using AI to Better Understand and Predict Brain Tumour Growth
-
Ultrasound-guided, multi-drug delivery for Glioblastoma
-
Preventing Glioblastoma Recurrence Using a Post-surgery Drug Paste
-
Targeting Meningioma through immune interactions
-
Targeting Treatment Resistance in Gliomas to Rapidly Push CAR-T Cell Therapies to Clinic
-
Blocking DNA Repair in Gliomas to Overcome Resistance
-
Detecting Tumour DNA in Blood Samples to Monitor Gliomas After Treatment